CELESTIAL — Celestial Biolabs Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesMicro Cap
Annual income statement for Celestial Biolabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | R2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 275 | 329 | 387 | 428 | 490 |
| Cost of Revenue | |||||
| Gross Profit | 215 | 140 | 109 | 141 | 203 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 221 | 300 | 350 | 387 | 467 |
| Operating Profit | 53.8 | 28.5 | 36.9 | 41.3 | 23 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 12.3 | 18.5 | 36.7 | 41.1 | 14 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13 | 20.8 | 33.3 | 33.3 | -0.281 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 13 | 20.8 | 33.3 | 33.3 | -0.281 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 13 | 20.8 | 33.3 | 33.3 | -0.281 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.698 | 0.92 | 1.48 | 1.47 | -0.012 |
| Dividends per Share |